Trial intelligence / Profile preview

Tiotropium vs Salmeterol on Muscular Efficiency in COPD

NCT02172794Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
May 2002
Primary completion
Oct 2005
Modality
Small Molecules
01

Overview

A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started May 2002; status: completed.

02

Drugs

tiotropium
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02172794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02172794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call